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Irritable bowel syndrome (IBS) is a chronic disorder that affects the
gastrointestinal system (GI) and is associated with abdominal pain and
changes in bowel movements. The standard first-line dietary interventions for
IBS are healthy eating and lifestyle changes. Once these diets are associated
with failure, more intense therapies are necessary. New approaches for
management of symptoms of IBS-D/IBS-C and quality of life has emerged
such as a low fermentable oligo-, di-, monosaccharides, and polyols
(FODMAP) diet because of its elimination process. This study found several
studies through a literature review that adults (≥ 18 years old) benefitted from
this novel therapy. More research is needed until a low FODMAP diet
intervention can be confirmed as effective or superior to other dietary
guidelines or restrictions.

Introduction
Irritable Bowel Syndrome (IBS)
Overview
➢ Altered GI motility, visceral hypersensitivity, and/or altered brain-gut axis
➢ Affects ~10% of the adult population globally
➢ Certain foods can be a trigger to GI symptoms
Symptoms
➢ Abdominal pain, changes in bowel movements – diarrhea and/or
constipation, bloating, flatus, fatigue and difficulty sleeping
➢ Associated with anxiety, depression, and decreased quality of life
Treatment
➢ 1st line dietary interventions for IBS are healthy eating and lifestyle
changes
➢ Currently, a low FODMAP intervention diet is a novel approach to treat IBS
symptoms.
➢ Therefore, this review analyzes the use of a low fermentable oligo-, di-,
monosaccharides, and polyols (FODMAP) diet (I) for management of
symptoms of IBS-D/ IBS-C and quality of life (O) in adults ((≥ 18 years
old) with Irritable Bowel Syndrome (P) comparable to other dietary
guidelines or restrictions (C).

Methods
Literature Search
➢ Performed in October 2018 using
✓Clinical Key
✓PubMed

Discussion

Results

Abstract

4/7 studies report that a low FODMAP diet has equal or greater efficacy
than 1st line of healthy eating and lifestyle changes in the treatment of IBS
&
3/7 studies report that a GFD diet has equal or greater efficacy than 1st
line of healthy eating and lifestyle changes in the treatment of IBS
Strengths
➢ All studies are RCT → allows for unbiased distribution of confounding
variables
➢ Statistically significant results → 7/7 studies used p-values < 0.05
➢ Blinding Methods → minimized bias and maximized the validity of the
3. Eswaran S, Chey WD, Jackson K, Pillai S, Chey SW, Han-Markey T. A Diet Low in Fermentable Oligo-, Di-,
results
and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With
➢ No study reported negative side-effects of the dietary interventions
Irritable Bowel Syndrome and Diarrhea. Clinical Gastroenterology and Hepatology. 2017;15(12).
Limitations
doi:10.1016/j.cgh.2017.06.044
➢ Small sample sizes
➢ RCT of 79 participants designed to test the efficacy of a low FODMAP diet in the treatment of IBS-C/IBS-D
➢ Recruitment methods
when compared to a mNICE diet
➢ Short study duration with only one study having an 18-month follow-up
4. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A Diet Low in FODMAPs Reduces Symptoms of Future Research
Irritable Bowel Syndrome. Gastroenterology. 2014;146(1). doi:10.1053/j.gastro.2013.09.046.
➢ Comparing a low FODMAP and GFD dietary intervention
➢ RCT of 38 participants designed to test the efficacy of low FODMAP diet in the treatment of IBS-C/IBS-D
➢ Recruit larger, more diverse population samples
when compared to a diet containing FODMAP’s of a typical Australian diet
➢ Long-term effects of low FODMAP and GFD diet
5. Hustoft TN, Hausken T, Ystad SO, et al. Effects of varying dietary content of fermentable short-chain
➢ Cost effectiveness of adhering to the diet
1. Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M, Sanders DS. Efficacy of a Gluten-Free Diet in
Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clinical
Gastroenterology and Hepatology. 2016;14(5). doi:10.1016/j.cgh.2015.12.031
➢ RCT of 41 participants designed to test the efficacy of a GFD diet with HLA-DQ2/8 positive genotype in the
treatment of IBS-C/IBS-D when compared to a GFD with HLA-DQ2/8 negative genotype
2. Böhn L, Störsrud S, Liljebo T, et al. Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel
Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology
2015;149(6). doi:10.1053/j.gastro.2015.07.054
➢ RCT of 66 participants designed to test the efficacy of a low FODMAP diet in the treatment of IBS-C/IBS-D
when compared to a traditional IBS diet

carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel
syndrome. Neurogastroenterology & Motility. 2016;29(4). doi:10.1111/nmo.12969

➢ RCT of 20 participants designed to test the efficacy of a low FODMAP diet in the treatment of IBS-C/IBS-D
when compared to a high FODMAP diet
6. Shahbazkhani B, Sadeghi A, Malekzadeh R, et al. Non-Celiac Gluten Sensitivity Has Narrowed the
Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial. Nutrients.
2015;7(6):4542-4554. doi:10.3390/nu7064542
➢ RCT of 72 participants designed to test the efficacy of a GCD diet in the treatment of IBS-C/IBS-D when
compared to a GFD diet
7. Vazquez–Roque MI, Camilleri M, Smyrk T, et al. A Controlled Trial of Gluten-Free Diet in Patients With
Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function. Gastroenterology.
2013;144(5). doi:10.1053/j.gastro.2013.01.049
➢ RCT of 45 participants designed to test the efficacy of a GFD diet in the treatment of IBS-C/IBS-D when
compared to a GCD diet

Table 1. Comparison of Results

The study results are positive, however more research is needed in order to
make a definitive conclusion. For the patients suffering from IBS who have
failed current first-line dietary recommendations and lifestyle modifications, a
low FODMAP appears to be a practical and potentially effective option.
Until more research is available, it remains unclear if symptom relief provided
by a low FODMAP diet can be sustained for long-term IBS management after
the elimination phase and reintroduction phase. There is not yet enough
evidence to validate a change in the standard IBS treatment practice, however
there are significantly enough positive results to promote future research.
In regards to future research, it should aim to compare a low FODMAP and
GFD dietary intervention and their effectiveness in the management of
symptoms and quality of life, as well as, the long term effectiveness of these
interventions.

Study

Demographics

Control Diet

Interventional Diet

Diet Length

1

Female: 31
Male: 10

GFD with HLA-DQ2/8 negative

GFD with HLA-DQ2/8 positive

6 wks

2

Female: 56
Male: 11
Female: 65
Male: 27

Traditional IBS diet

Low FODMAP

mNICE

Low FODMAP

3
4

Female: 27
Male: 11

Diet containing FODMAP
content of a typical Australian
diet

Low FODMAP

5

➢ Seven articles consisting of randomized control trials (RCT) were selected
based on their relevance to the research question, intervention technique,
sample population, and outcome measures. These articles were later
compared based on their study design, results, and statistical relevance.

Conclusion

Female: 15
Male: 5
6

Female: 53
Male: 19

Low FODMAP

GFD

High FODMAP

GCD

Outcome Measure

IBS-SSS, HADS, FIS, SF-36 QOL

29 days

IBS-SSS, BSFS, HADS, VSI, Multidimensional Fatigue
Inventory-20

4 wks

BSFS, IBS-QOL, HADS, Work Productivity and Activity
Impairment, Seep and Fatigue

21-day diet, washout pd of at least 21 days, then
cross over to 21-day to the alternate diet

Gastrointestinal symptoms were measured by VAS, KSC

2 day IBS school, 9 wks of LFD, then after 3 wks
supplement of either high FODMAP (A) or low
FODMAP (B) followed by a 3-wk washout, and then
reverse sequence

IBS-SSS

6 wks GFD, then 6 wks of either GFD or GCD

Bloating, abdominal pain, defecation satisfaction, nausea,
fatigue, and overall symptoms, and scored with the VAS

Female: 43
GCD
BSFS, HADS, HLA Genotyping, Measurement of Gastric
GFD
4 wks
7
Male: 2
Emptying, Small Bowel and Colonic Transit with Scintigraphy
Key: IBS-SSS: IBS-Symptom Severity Score, HADS: Hospital Anxiety and Depression Scale, SF-QOL: Short-form 36 Quality of Life; GFD: Gluten-Free Diet, VAS: Visual analogue scale, KSC: King’s Stool Chart, BSFD: Bristol Stool
Form Scale, FODMAP: Fermentable oligo-, di-, monosaccharides, and polyols

